Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Astellas

Astellas Pharma

Rank: 23

Tokyo, Japan
www.astellas.com

2020 Revenues ($USD) : $11,701,891,740
2020 Revenues (foreign currencies) : JP¥1249528000000
2020 R&D spend : $2,102,350,627.46
2020 Number of Employees : 15,455
Fiscal Year End : 3/31/2021
Key People : Kenji Yasukawa, CEO; Naoki Okamura, corporate EVP, chief strategy officer and CFO; Fumiaki Sakurai, CAO and chief ethics & compliance officer; Dr. Bernhardt Zeiher, chief medical officer; Yukio Matsui, CCO; Yoshitsugu Shitaka, chief scientific officer; Percival Barretto-Ko, chief business officer; Catherine Levitt, general counsel

Astellas Pharma is a Tokyo-based company developing pharmaceuticals for a broad range of therapeutics, including cardiology, immunology, infectious disease, oncology and urology. The company commercializes 12 drugs in the U.S., with its Xtandi prostate-cancer-treating drug leading sales in its most recent fiscal year. –DK

The Astellas Institute for Regenerative Medicine. Image courtesy of Astellas.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE